Cellebrite DI Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Cellebrite DI Ltd. (CLBT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $5.81 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-03
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|
| 2025-12-31 | $5.81 20-F · filed 2026-03-03 | |
| 2024-12-31 | $5.81 20-F · filed 2025-03-18 | |
| 2024-06-30 | $5.50 6-K · filed 2025-08-14 | |
| 2023-12-31 | $3.59 20-F · filed 2026-03-03 | |
| 2023-06-30 | $2.65 6-K · filed 2024-08-15 | |
| 2022-12-31 | $2.86 20-F · filed 2025-03-18 | |
| 2021-12-31 | $5.04 20-F · filed 2024-03-21 | |
| 2020-12-31 | $0.74 20-F · filed 2022-03-29 |